KevinSBuckleyMD
Pediatric Infectious Disease • Charlotte, NCPediatric Infections Associated with Transplant/Immunocompromised States
Physician
Dr. Buckley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 Blythe Blvd
Medical Center Plaza Suite 200
Charlotte, NC 28203Phone+1 704-381-8840
Education & Training
University of Alabama Medical CenterFellowship, Pediatric Hematology/Oncology, 2003 - 2007- University of Alabama Medical CenterFellowship, Pediatric Infectious Diseases, 2003 - 2007
- University of Alabama Medical CenterChief Residency, Pediatrics, 2002 - 2003
- University of Alabama Medical CenterResidency, Pediatrics, 1999 - 2002
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1999
Certifications & Licensure
GA State Medical License 2022 - 2025
NC State Medical License 2009 - 2025
DC State Medical License 2007 - 2010
AL State Medical License 2000 - 2007- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Epigenetic and Metabolomic Changes in Childhood Cancer Survivors Start of enrollment: 2019 Feb 25
Publications & Presentations
PubMed
- Blastic plasmacytoid dendritic cell neoplasm with t(2;8)(p12;q24).Andrew P. Seiwell, Kevin Buckley, Mark J. Pettenati, David D. Grier
Pediatric Blood & Cancer. 2020-03-01 - Accelerated Unilateral Radiographic Huntingtonian Changes Following Neoadjuvant Chemotherapy for a Nongerminomatous Germ Cell Tumor Leading to Identification of Occult...John T. Lucas, Michael E. Zapadka, Kristin W. Houseknecht, Kevin S. Buckley, Daniel E. Couture
Journal of Pediatric Hematology/oncology. 2016-03-01 - 11 citationsRecirculating bone marrow B cells in C57BL/6 mice are more tolerant of highly hydrophobic and highly charged CDR-H3s than those in BALB/c miceMohamed Khass, Kevin Buckley, Pratibha Kapoor, Robert L. Schelonka, Leticia S. Watkins
European Journal of Immunology. 2013-03-01
Professional Memberships
- Childrens Oncology GroupMember
- International Society for Computational BiologyMember
- American Society of TransplantationMember
- Pediatric Infectious Diseases SocietyMember
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
